Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer

被引：0
|
作者：
Seema Agarwal
Frank B Gertler
Michele Balsamo
John S Condeelis
Robert L Camp
Xiaonan Xue
Juan Lin
Thomas E Rohan
David L Rimm
机构：
[1] Yale University School of Medicine,Department of Pathology
[2] Massachusetts Institute of Technology,Department of Biology and Koch Institute for Integrative Cancer Research
[3] Albert Einstein College of Medicine,Department of Anatomy and Structural Biology, Gruss Lipper Biophotonics Center
[4] Albert Einstein College of Medicine,Department of Epidemiology and Population Health
来源：
Breast Cancer Research | / 14卷
关键词：
Breast Cancer; Benzoic Hydrazide; Index Array; Haven Hospital; Mouse Breast Cancer Model;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Survivin is an independent prognostic marker for risk stratification of breast cancer patients
    Span, PN
    Sweep, FCGJ
    Wiegerinck, ETG
    Tjan-Heijnen, VCG
    Manders, P
    Beex, LVAM
    De Kok, JB
    CLINICAL CHEMISTRY, 2004, 50 (11) : 1986 - 1993
  • [22] Moesin is an independent prognostic marker for ER-positive breast cancer
    Yu, Lifeng
    Zhao, Lin
    Wu, Huizhe
    Zhao, Haishan
    Yu, Zhaojin
    He, Miao
    Jin, Feng
    Wei, Minjie
    ONCOLOGY LETTERS, 2019, 17 (02) : 1921 - 1933
  • [23] Yes-associated Protein Is Not an Independent Prognostic Marker in Breast Cancer
    Sheen-Chen, Shyr-Ming
    Huang, Chun-Ying
    Tsai, Ching-Hua
    Liu, Yueh-Wei
    Wu, Shih-Chung
    Huang, Chao-Cheng
    Eng, Hock-Liew
    Chan, Yi-Chia
    Ko, Sheung-Fat
    Tang, Rei-Ping
    ANTICANCER RESEARCH, 2012, 32 (08) : 3321 - 3325
  • [24] TIGIT as a Novel Prognostic Marker for Immune Infiltration in Invasive Breast Cancer
    Guo, Chenming
    Luo, Zhiwen
    Ismtula, Dilimulati
    Bi, Xiaojuan
    Kong, Han
    Wang, Yiyang
    Yang, Zhen
    Mao, Xinmin
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26 (03) : 639 - 651
  • [25] miR-320a is an independent prognostic biomarker for invasive breast cancer
    Yang, Haiping
    Yu, Juan
    Wang, Lei
    Ding, Di
    Zhang, Lei
    Chu, Chengyu
    Chen, Qi
    Xu, Zude
    Zou, Qiang
    Liu, Xiuping
    ONCOLOGY LETTERS, 2014, 8 (03) : 1043 - 1050
  • [26] Methods of Nucleolar Assessment in Invasive Breast Cancer and their Prognostic Significance
    El-Sharawy, K. A.
    Dalton, L. W.
    Toss, M. S.
    Abuelmaaty, S. R.
    Mongan, N. P.
    Ellis, I. O.
    Green, A. R.
    Aleskandarany, M. A.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2019, 249 : S26 - S26
  • [27] Overexpression of LAPTM4B: an independent prognostic marker in breast cancer
    Xiao, Min
    Jia, Shusheng
    Wang, Hongbin
    Wang, Jinsong
    Huang, Yuanxi
    Li, Zhigao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (04) : 661 - 667
  • [28] CD133 is an independent predictive and prognostic marker in metastatic breast cancer
    Hefni, Ahmed Mubarak
    Sayed, Ayat Mohammed
    Hussien, Marwa T.
    Abdalla, Ashraf Zeidan
    Gabr, Adel Gomaa
    CANCER BIOMARKERS, 2022, 35 (02) : 207 - 215
  • [29] 17β-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer
    Oduwole, OO
    Li, Y
    Isomaa, VV
    Mäntyniemi, A
    Pulkka, AE
    Soini, Y
    Vihko, PT
    CANCER RESEARCH, 2004, 64 (20) : 7604 - 7609
  • [30] Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer
    Hachim, Ibrahim Y.
    Hachim, Mahmood Y.
    Lopez, Vanessa M.
    Lebrun, Jean-Jacques
    Ali, Suhad
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (04) : 238 - 245
12345